Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Obstetrics and gynaecology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Intrauterine fetal death and bereavement care

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Fetal death with maternal illness

Sepsis, placental abruption, pre-eclampsia or major bleeding can threaten the mother's life alongside the loss of the baby.

Action: Assess observations and maternal symptoms immediately, involve senior obstetrics and appropriate emergency teams, treat the underlying illness and plan timely birth while providing compassionate support.

Overview

Confirm fetal death sensitively, identify maternal illness and potentially informative investigations, and provide safe birth planning and continuing bereavement care.

Intrauterine fetal death is a devastating diagnosis that changes the aims of obstetric care but does not end the need for physical assessment. The RCOG late-IUFD guideline covers singleton death after 24+0 weeks; earlier loss and a surviving co-twin need different specialist pathways even though many communication principles are shared. Reduced movement or inability to detect a heartbeat should lead to appropriate ultrasound confirmation. Show and explain the findings if the patient wishes, obtain a second opinion where uncertainty exists and document confirmation before discussing an irreversible intervention.

Communication should be direct and unhurried. Say clearly that the baby has died, acknowledge the loss and avoid euphemisms that can leave the diagnosis uncertain. Pause for questions and recognise that information may need to be repeated. Ask whom the patient wants present and how they refer to their baby. Provide a private environment with clinically appropriate access to care, a named professional and written contact details. Do not

Aetiology

01

Placental or cord pathology

Placental dysfunction, abruption, substantial fetomaternal haemorrhage and some cord events can impair oxygen delivery, although causal attribution requires careful correlation with investigations.

02

Maternal or fetal conditions

Infection, maternal metabolic or hypertensive disease, fetal genetic abnormalities and structural conditions can contribute to fetal death, with some cases remaining unexplained after assessment.

Pathophysiology

  1. 1
    Failure of fetal oxygen supply

    Antenatal compromise can develop through impaired placental exchange, interruption of cord circulation or severe fetal anaemia, eventually causing irreversible fetal circulatory failure.

  2. 2
    Maternal disease continues

    The condition associated with fetal death, such as sepsis or placental abruption, can continue to threaten maternal organs and requires treatment independent of fetal outcome.

  3. 3
    Loss triggers postpartum physiology

    After birth the uterus involutes and lactation may begin despite bereavement, creating physical care needs that can intensify distress if they are not anticipated.

Clinical features and red flags

Absent or changed fetal movements

A report of reduced or absent movement requires prompt maternity assessment; assumptions about sleep or a quieter late-pregnancy fetus should not replace evaluation.

Uncertain auscultation

Failure to hear a fetal heart using a handheld device can result from technical factors and requires real-time ultrasound before confirming death.

Maternal associated disease

Fever, pain, bleeding, hypertension or systemic illness may point to a cause that also needs immediate treatment for the mother's safety.

Acute emotional distress

Shock, disbelief, dissociation or inability to retain information requires repeated explanation, a support person if wanted and a dependable named contact.

Red flags requiring action

  • Fever, haemodynamic deterioration, severe abdominal pain, heavy bleeding or severe hypertension requires urgent assessment and treatment rather than routine bereavement-only follow-up.
  • After discharge, suicidal thoughts, inability to remain safe, chest pain, breathlessness, heavy bleeding or systemic illness needs immediate clinical help.

Investigations

  1. 01
    Real-time ultrasound confirmationFirst step
    Why
    Demonstrate absent fetal cardiac activity and resolve any diagnostic uncertainty before birth planning.
    Interpretation and limitations
    A suitably trained clinician should confirm and document the findings; offer a second opinion if there is doubt or if this would help the patient understand.
  2. 02
    Maternal blood count, biochemistry and coagulation
    Why
    Assess anaemia, organ dysfunction, hypertensive disease, infection and possible consumptive coagulopathy.
    Interpretation and limitations
    Select and repeat tests according to the clinical picture, with fibrinogen and coagulation assessment especially relevant to abruption, sepsis and neuraxial planning.
  3. 03
    Prompt fetomaternal-haemorrhage assessment
    Why
    Investigate a potentially causal large fetal bleed and guide anti-D dosing when relevant.
    Interpretation and limitations
    Obtain before birth wherever possible because fetal cells may clear; this causal investigation can be indicated even when the mother is RhD positive.
  4. 04
    Repeat treponemal serology and targeted infection tests
    Why
    Identify treatable infection and a possible explanation with future-pregnancy implications.
    Interpretation and limitations
    The corrected RCOG recommendation repeats syphilis serology at IUFD presentation regardless of booking status; other microbiology follows symptoms and specialist assessment.

Differential diagnosis

01

Technical failure to detect a heartbeat

Fetal position, maternal habitus or equipment limitations can prevent auscultation despite a living fetus, making ultrasound confirmation essential before declaring death.

02

Severe fetal compromise without death

Markedly reduced movement or an abnormal heart-rate assessment may indicate a living fetus requiring urgent rescue rather than a confirmed bereavement pathway.

03

Earlier pregnancy loss

Loss before the late-IUFD guideline's gestational scope requires its own medical, legal and procedural pathway, while sensitive communication and maternal assessment remain equally necessary.

Management

01ConfirmationEstablish the diagnosis and immediate needsFirst stepAssessment raises concern that the fetus may have died before birth.+
  1. 1Arrange ultrasound confirmation while assessing maternal observations, pain, bleeding and possible infection or hypertensive disease.
  2. 2Communicate the diagnosis clearly in private, allow silence and questions, and offer chosen support and a professional interpreter when required.
  3. 3Provide a named maternity contact and begin time-sensitive maternal and causal investigations without overwhelming the patient with every decision at once.
02BirthAgree safe timing and an individual induction planDeath is confirmed and the patient is ready to discuss birth or maternal illness makes birth urgent.+
  1. 1Explain vaginal and caesarean options, including physical and psychological consequences, and recommend vaginal birth for most patients while respecting individual circumstances.

Complications

01

Maternal haemorrhage or sepsis

Associated placental disease, infection, induction or retained tissue can cause significant maternal morbidity before or after birth and requires active surveillance and treatment.

02

Thromboembolic risk

Stillbirth contributes to postpartum VTE risk, so individual assessment and appropriately timed prophylaxis are needed while accounting for bleeding and coagulation status.

03

Persistent psychological morbidity

Grief may coexist with depression, post-traumatic stress, relationship strain or suicidal thinking; access to compassionate support and targeted mental-health care should continue beyond discharge.

Monitoring and follow-up

  • Continue maternal clinical observations and repeat laboratory testing during any interval before birth according to bleeding, infection, hypertensive disease and coagulation risk.
  • Monitor contractions, pain and maternal physiology throughout induction and escalate unexpected severe pain, bleeding or signs of uterine rupture.
  • Before discharge document VTE assessment, bleeding and anaemia management, lactation preferences, medication advice and a clear route to urgent help. After cabergoline monitor blood pressure and urgently assess severe persistent headache, visual disturbance or chest pain.
  • Ensure every requested investigation has a responsible clinician and results pathway, including placental histology, genetics, infection tests and postmortem findings.
  • At follow-up ask about sleep, functioning, mood, trauma symptoms, relationships and safety, offering bereavement, psychological or urgent mental-health support as needed.

Special situations

A booking test is not enough

The published correction to Green-top 55 specifically requires repeat treponemal serology at presentation, because an earlier result cannot exclude later infection.

Consent can be revisited

Families may need time to consider postmortem options and memory-making; explain time-sensitive aspects gently and avoid presenting a single hurried conversation as their only opportunity.

A stillbirth remains a birth

Analgesia, respectful intrapartum care, postpartum physiology and practical support remain essential even when the infant cannot survive.

Cause and recurrence need precision

An abnormal placental finding may contribute to the explanation without proving every mechanism; counselling should distinguish established findings from reasonable uncertainty.

A surviving co-twin changes management

Singleton late-IUFD induction advice must not be applied automatically to a multiple pregnancy with a surviving fetus, which needs fetal-medicine assessment.

Common pitfalls

  1. 01

    Confirming fetal death solely because a handheld Doppler cannot detect a heartbeat.

  2. 02

    Omitting repeat syphilis serology because the booking infection screen was negative.

  3. 03

    Using an unscarred-uterus misoprostol schedule automatically after a previous caesarean at later gestation.

  4. 04

    Neglecting lactation, VTE risk or psychological safety because the immediate obstetric event has ended.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA

Repeating an infection investigation

A patient presents with confirmed IUFD at 32 weeks. The booking syphilis screen was negative and no new sexual history concern is reported. Which action reflects the published correction to RCOG Green-top 55?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Obstetrics and gynaecology topics →
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • RCOG Green-top 55 late intrauterine fetal death and stillbirth
  • Published correction to RCOG Green-top 55 investigation table
  • NICE NG207 induction after intrauterine fetal death
  • Cabergoline UK summary of product characteristics
  • BSH anti-D immunoglobulin prevention guidance
  • RCOG information when a baby dies before birth

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
assume religious, cultural or family preferences from appearance or background. Seeing, holding, naming or photographing the baby are choices to offer respectfully, not obligations to impose.

Maternal assessment starts immediately: look for infection, haemorrhage, placental abruption and hypertensive or metabolic disease. Obtain relevant haematology, biochemistry and coagulation assessment, with fibrinogen and specialist advice when consumption is possible or regional anaesthesia is planned. Collect a fetomaternal-haemorrhage sample promptly before birth wherever possible, including in RhD-positive patients when investigating cause. Earlier routine infection screening is not a reason to omit all repeat tests: the corrected RCOG recommendation specifically requires treponemal serology at IUFD presentation regardless of the booking result.

Investigations should answer what happened and what might matter in another pregnancy. Placental histology is particularly valuable, and genetic testing and postmortem examination should be offered with informed consent and discussion of less invasive alternatives where available. Explain specimen handling and who will discuss results. Test for specific maternal infection or disease when the presentation supports it, avoiding indiscriminate panels whose incidental findings may confuse rather than explain the loss. Even a thorough assessment may leave uncertainty; do not turn a risk factor or association into a proven cause.

Vaginal birth is suitable for most patients and avoids the added surgical consequences of caesarean birth without a fetal benefit. Nevertheless, individual physical circumstances and the patient's psychological needs deserve a careful discussion. If the mother is well, membranes are intact and there is no bleeding or infection, some time before induction may be acceptable with an agreed surveillance plan. Urgent maternal indications require earlier birth. Mifepristone followed by a prostaglandin is generally recommended for induction, but gestation and prior uterine surgery govern the regimen. A scarred uterus, particularly from 28 weeks, requires consultant planning rather than mechanically applying an unscarred-uterus schedule.

Recovery includes grief, practical needs and ongoing medical risk. Offer analgesia during labour and discuss lactation before milk production becomes distressing. Review VTE risk, bleeding, anaemia, infection and blood pressure after birth. Arrange communication with primary care and community maternity services and stop automated antenatal invitations where possible. Offer a follow-up discussion once investigation results are available, with a written explanation, options for support and a future-pregnancy plan when the patient wants one. Grief should not be pathologised, but severe depression, trauma symptoms and self-harm risk need active assessment and access to treatment.

Key points

  • Confirm absent fetal cardiac activity with real-time ultrasound by a suitably trained clinician; difficulty hearing a heartbeat alone is insufficient.
  • Use clear compassionate language, allow time and privacy, and offer a support person and professional interpreter where needed.
  • Evaluate maternal wellbeing and treat sepsis, abruption or hypertensive disease promptly; fetal death does not remove obstetric urgency.
  • Offer investigations directed at cause and recurrence, including placental histology, consented genetic assessment and postmortem options.
  • Repeat treponemal serology at presentation with IUFD regardless of booking status, as specified in the published correction to RCOG Green-top 55.
  • Vaginal birth is recommended for most patients, with induction method and timing tailored to gestation, uterine scars, clinical condition and preferences.
  • Offer lactation advice, VTE assessment, bereavement support and a named follow-up contact, and cancel routine pregnancy communications sensitively.
  • 05
    Placental histology, genetics and postmortem options
    Why
    Look for placental disease, fetal abnormalities and other findings that can clarify cause or recurrence.
    Interpretation and limitations
    Offer informed choices and obtain the relevant consent, explain limitations and ensure appropriate specimens reach the laboratory with the clinical history.
    • 2
    For an unscarred uterus use the consultant-approved mifepristone and gestation-specific prostaglandin plan, with adequate analgesia and maternal monitoring.
  • 3With previous caesarean or other transmural surgery, obtain a specific consultant plan for induction and rupture risk; do not extrapolate a universal misoprostol schedule from unscarred pregnancies.
    • 03AftercareSupport recovery and complete the explanationBirth has occurred and the family is considering investigations, memories and discharge.+
    1. 1Offer opportunities for seeing or holding the baby and memory-making according to the family's wishes, alongside consented postmortem and genetic discussions.
    2. 2Review bleeding, infection, VTE risk, anaemia and lactation, provide written urgent-return advice and coordinate community and primary-care support.
    3. 3Arrange a results appointment and bereavement contact, explain unresolved questions honestly and develop a future-pregnancy plan when the patient is ready.
    Key medicines and prescribing safety4 treatments · regimens, roles and cautions+
    Prepares the uterus and cervix and improves the induction pathway when vaginal birth is planned.

    Mifepristone before induction after late IUFD

    For the RCOG combination induction approach, give mifepristone 200 mg orally as a single dose, followed by the gestation-appropriate prostaglandin regimen at the interval specified in the consultant-led induction protocol.

    Assess uterine scars, maternal stability, adrenal insufficiency, long-term corticosteroid treatment and product-specific contraindications; do not delay urgent birth simply to follow an elective interval.

    Induces uterine contractions after confirmed fetal death when the individual obstetric plan supports this approach.

    Misoprostol for an unscarred uterus after late IUFD

    RCOG regimens after mifepristone are: at 24+0–24+6 weeks, 400 micrograms buccally, sublingually, vaginally or orally every 3 hours; at 25+0–27+6, 200 micrograms by those routes every 4 hours; from 28+0, 25–50 micrograms vaginally every 4 hours or 50–100 micrograms orally every 2 hours. Stop or withhold for established adequate labour, hyperstimulation or concern, using the unit's specified review and maximum-dose rules.

    This indication is off label in the UK. Do not apply these schedules automatically to a previous caesarean or transmural scar, particularly from 28 weeks; pharmacy preparation and accurate microgram dosing are essential.

    Reduces distressing milk production and breast discomfort after birth when lactation inhibition is desired.

    Cabergoline for lactation inhibition

    When appropriate and chosen by the patient, cabergoline 1 mg orally as a single dose during the first postpartum day inhibits lactation; established lactation uses a different divided-dose regimen.

    Check product contraindications including toxaemia of pregnancy and puerperal psychosis history, and review postpartum hypertension and hypotension risk with the prescribing clinician; offer non-drug measures when unsuitable.

    Prevents future RhD alloimmunisation when fetal red-cell exposure accompanies the loss.

    Anti-D following late fetal death

    For a non-sensitised RhD-negative patient after 20 weeks, give at least 500 IU anti-D intramuscularly, or intravenously only with a product licensed for that route, within 72 hours of the IUFD diagnosis. Quantify fetomaternal haemorrhage for additional dosing and reassess requirements after birth.

    The IUFD diagnosis starts the 72-hour clock; do not wait for induction or delivery. Confirm immune versus passive anti-D with the laboratory where uncertain, and assess any separate postpartum prophylaxis requirement.